ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Jennifer N Brudno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.